MS Ventures Israel Bioincubator Fund is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to invest in biomedical innovation in Israel, the Bioincubator offers both seed financing and access to dedicated laboratory facilities within Merck Serono's based R&D center. Through the incubator initiative, we have committed to invest up to EUR 10 million in early stage opportunities.